Director · MAIA Biotechnology, Inc. · Common Stock
Side
G
Value
—
Shares
20.0K
Price
—
Executed
May 1, 2024
Disclosed
Jan 12, 2026
Disclosure timeline621 days from execution to publication · legal deadline 2 business days
May 1 executedJan 12, 2026 disclosed
MAIA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 443 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Smith Stan filed this Form 4 reporting a gift of MAIA on May 1, 2024. It became public on Jan 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Smith Stancik:0001913199
Issuer
MAIA Biotechnology, Inc.cik:0001878313
Revision history · 0
No field has changed since this record was first ingested.
